Delivery Order W81K0017D0008-0004
Award Date 10/1/17
Potential Completion Date 9/30/18
Potential Value $21K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Fort Bliss, TX 79918, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, with ID SPE2DX15D3404|SPE2DX24F0YJF, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order valued at $3,773.42 for the supply of 400 mg/200 mL of the pharmaceutical product Ropivacaine 0.2%. The contract has no set-aside designation, indicating open competition. It is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc....
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,162.25 firm fixed-price delivery order is for 4563554227 - Ropivacaine 0.2% 400 mg/200 ml, a pharmaceutical product used for pain management. The contract has an ultimate completion date of February 6, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,174.42 firm fixed-price delivery order is for the supply of Ropivacaine 0.2% 400 mg/200 ml medication, with a completion date of January 29, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary...
- On January 14, 2026, the Defense Logistics Agency awarded a delivery order valued at $1,460.25 to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.2% 400 mg/200 mL in 200 mL quantities. This non-competitive, firm fixed-price delivery order is scheduled for completion by January 15, 2026, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- This is a federal delivery order (contract) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 400 mg/200 mL ropivacaine 0.2% in 200 mL doses, with a ceiling value of $6,449.98 and a completion date of June 18, 2024. The contract is a firm fixed-price delivery order and is not designated as a set-aside. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,639.35, is for the delivery of Ropivacaine 0.2% 400 mg/200 ml medication. The contract is a Firm Fixed Price Delivery Order with a completion date of February 24, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 400 mg/200 mL ropivacaine 0.2% injectable medication. The order is valued at $9,108.78 with a completion date of February 1, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen is a major pharmaceutical distributor that supplies medical products to various federal agencies, including...
- The Defense Logistics Agency awarded a $4,400.42 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL), a local anesthetic pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded a $1,154.95 delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 ml) pharmaceutical product, with completion scheduled for December 15, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- This federal contract award is for the delivery of Ropivacaine 0.2% 400 mg/200 ml medication, valued at $4,820.26, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...